Trump signs order to boost domestic drug manufacturing as pharma tariff threat looms
- President Donald Trump signed an executive order to incentivize drug manufacturing in the U.S., streamlining the path for pharmaceutical companies to build new production sites.
- The order comes ahead of Trump's planned tariffs on pharmaceuticals imported into the U.S., as the U.S. Imported $203 billion in pharmaceutical products in 2023.
- Some pharmaceutical companies are pushing back on Trump's plans, as reshoring manufacturing could elevate production costs and drug prices, raising affordability concerns.
63 Articles
63 Articles
Trump poised to declare war on powerful industry — and set up 'major confrontation'
President Donald Trump is preparing to go to war with the pharmaceutical industry as the White House plans to unveil a sweeping plan to slash Medicare drug prices by linking them to lower costs abroad, according to a new report in Politico.Trump is expected to sign an executive order early next week...
Coverage Details
Bias Distribution
- 50% of the sources lean Right
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage